U.S. Announces Negotiated Prices for 15 Drugs Under Medicare

The U.S. government has announced negotiated prices for 15 drugs under Medicare, the federal health insurance program for the elderly and disabled. The new prices are expected to result in significant savings for the program. According to the Trump administration, if the new prices had been in effect last year, Medicare would have saved $12 billion, which would have reduced its spending on those drugs by 44 percent. The administration claims that the negotiated prices will provide relief to both Medicare and its beneficiaries. The announcement is part of the government's efforts to lower drug prices and increase transparency in the healthcare system. The negotiated prices are the result of a pilot program that allows Medicare to directly negotiate with pharmaceutical companies, a departure from the traditional approach where the government sets prices. The article highlights the ongoing efforts to address the high costs of prescription drugs in the U.S. and the potential impact of these negotiations on the overall healthcare system.